Get the Stockscreener App
11.89
0.25%
-0.03
After Hours:
11.89
Medifast Inc stock is traded at $11.89, with a volume of 111.50K.
It is down -0.25% in the last 24 hours and down -5.41% over the past month.
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. The company provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. The company is focused on offering talent to Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
See More
Previous Close:
$11.92
Open:
$12
24h Volume:
111.50K
Relative Volume:
0.49
Market Cap:
$132.21M
Revenue:
$346.10M
Net Income/Loss:
$-20.02M
P/E Ratio:
-6.5229
EPS:
-1.8228
Net Cash Flow:
$-1.47M
1W Performance:
-1.74%
1M Performance:
-5.41%
6M Performance:
-3.80%
1Y Performance:
-9.65%
1-Day Range:
$11.84
$12.04
1-Week Range:
$11.84
$12.39
52-Week Range:
$9.22
$15.46
Medifast Inc Stock (MED) Company Profile
Name
Medifast Inc
Sector
Industry
Phone
(410) 581-8042
Address
1501 S. CLINTON STREET, BALTIMORE, MD
Compare MED vs ROL, SCI, FTDR, HRB, ANDG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MED
Medifast Inc
|
11.89 | 132.54M | 346.10M | -20.02M | -1.47M | -1.8228 |
ROL
Rollins Inc
|
47.19 | 22.65B | 3.84B | 529.30M | 621.14M | 1.0945 |
SCI
Service Corp International
|
76.92 | 10.17B | 4.33B | 535.79M | 486.05M | 3.79 |
FTDR
Frontdoor Inc
|
68.83 | 4.74B | 2.12B | 260.00M | 385.00M | 3.5067 |
HRB
H R Block Inc
|
36.52 | 4.55B | 3.91B | 736.10M | 760.88M | 5.6238 |
ANDG
Andersen Group Inc
|
37.78 | 3.95B | 871.37M | -163.01M | 0 | 1.0456 |
Medifast Inc Stock (MED) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-05-24 | Upgrade | DA Davidson | Underperform → Neutral |
| Jun-05-24 | Downgrade | DA Davidson | Neutral → Underperform |
| Oct-13-23 | Initiated | Stephens | Equal-Weight |
| Nov-04-22 | Downgrade | DA Davidson | Buy → Neutral |
| Aug-04-22 | Downgrade | Jefferies | Buy → Hold |
| Jan-25-21 | Upgrade | Jefferies | Hold → Buy |
| Nov-05-20 | Upgrade | DA Davidson | Neutral → Buy |
| Jun-25-20 | Initiated | B. Riley FBR | Buy |
| Feb-27-20 | Downgrade | Jefferies | Buy → Hold |
| Nov-08-19 | Downgrade | Dougherty & Company | Buy → Neutral |
| Jul-25-19 | Initiated | Jefferies | Buy |
| Nov-08-18 | Upgrade | Sidoti | Neutral → Buy |
| Mar-07-18 | Upgrade | Sidoti | Neutral → Buy |
| Sep-15-17 | Reiterated | DA Davidson | Buy |
| Aug-04-16 | Reiterated | Wunderlich | Hold |
| Jan-11-16 | Upgrade | Sidoti | Neutral → Buy |
| Nov-30-15 | Downgrade | Sidoti | Buy → Neutral |
| Oct-05-15 | Upgrade | Sidoti | Neutral → Buy |
| Nov-07-14 | Downgrade | Imperial Capital | Outperform → In-line |
| Aug-08-14 | Reiterated | Imperial Capital | Outperform |
| Apr-23-14 | Reiterated | Imperial Capital | Outperform |
| Sep-06-13 | Initiated | Imperial Capital | Outperform |
| Nov-06-12 | Reiterated | Northland Securities | Outperform |
| Jul-27-12 | Upgrade | Northland Securities | Market Perform → Outperform |
| Jul-09-12 | Downgrade | Standpoint Research | Buy → Hold |
| Jan-30-12 | Initiated | Standpoint Research | Buy |
View All
Medifast Inc Stock (MED) Latest News
Metabolic Health After 40: What Perimenopause and Menopause Mean for Weight Management - GlobeNewswire
Medifast (MED) down 5.1% since last earnings report: Can it rebound? - MSN
MED News | MEDIFAST INC (NYSE:MED) - ChartMill
Medifast (MED) Down 5.1% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Is MEDIFAST (MED) Stock Outpacing Its Consumer Staples Peers This Year? - Yahoo Finance
Medifast chief legal officer Jason Groves resigns; company begins search for successor - Investing.com UK
Medifast chief legal officer Jason Groves resigns; company begins search for successor By Investing.com - Investing.com South Africa
Medifast (MED) Files 8-K Announcing Executive Separation Agreement with Jason Groves - Minichart
Medifast's Jason L. Groves resigns as Chief Legal Officer & Corporate Secretary - TradingView
[8-K] MEDIFAST INC Reports Material Event - Stock Titan
MED News Today | Why did Medifast stock drop today? $MED - MarketBeat
Medifast (MED) director takes equity awards instead of cash for board service - Stock Titan
Medifast (NYSE: MED) director Kiai Parsa takes equity grants in lieu of cash fees - Stock Titan
Medifast (MED) director receives 11,680 RSUs as annual fee compensation - Stock Titan
Medifast (NYSE: MED) director receives 11,680 restricted stock units award - Stock Titan
Medifast (NYSE: MED) director awarded 11,680 restricted stock units in fee grant - Stock Titan
Cash-settled RSU grant boosts Medifast (MED) director derivative holdings - Stock Titan
Medifast Inc (NYSE: MED) director Jeffrey Rose files routine Form 3 - Stock Titan
Medifast (NYSE: MED) director details 657,590 indirect shares - Stock Titan
What is Zacks Research's Forecast for Medifast Q2 Earnings? - MarketBeat
Medifast Appoints Nicholas Johnson as New CEO and Amends 2012 Share Incentive Plan - Minichart
Medifast Names Nicholas Johnson as CEO - Moomoo
MED Technical Analysis | Trend, Signals & Chart Patterns | MEDIFAST INC (NYSE:MED) - ChartMill
Medifast Taps Johnson to Succeed Chard as CEO - Moomoo
Medifast names Nicholas Johnson as CEO effective June 1 By Investing.com - Investing.com South Africa
Nicholas Johnson becomes Medifast (NYSE: MED) CEO as investors back equity plan - Stock Titan
Medifast, Inc. Approves Board Elections - marketscreener.com
Medifast names Nicholas Johnson as CEO effective June 1 - Investing.com
Medifast confirms appointment of Nicholas Johnson as chief executive officer - marketscreener.com
Medifast Confirms Appointment of Nicholas Johnson as Chief Executive Officer - Business Wire
Medifast reconfirms $270M-$300M 2026 revenue outlook as it targets profitability improvements starting in Q4 2026 - MSN
The Human Layer in Weight Management: What OPTAVIA's Coaching Model Is Built to Do - Sahm
The Human Layer in Weight Management: What OPTAVIA's Coaching Model Is Built to Do - GlobeNewswire Inc.
Weight Loss Coaching vs. App-Only Programs: What Published Research Shows About Long-Term Outcomes - Sahm
MEDIFAST INC (MED) Surges +1.12%, Nearing $13.22 Resistance 2026-05-19Call Spread Alert - thelegaladvocate.com
Citadel reports 6.5% stake in MEDIFAST (MED) in joint Schedule 13G - Stock Titan
MED | Medifast, Inc. FinancialsIncome Statement - Quiver Quantitative
Charles Schwab (MED) reports 631,539 shares, 5.74% stake (03/31/2026) - Stock Titan
Renaissance Holdings amends Schedule 13G: 773,710 shares in MED (MED) - Stock Titan
Why Medifast's $15 Cash Per Share Makes It A Strong Buy (NYSE:MED) - Seeking Alpha
Medifast director Scott Schlackman buys $62,950 in company stock By Investing.com - Investing.com Nigeria
Medifast director Scott Schlackman buys $62,950 in company stock - Investing.com
Medifast (MED) director Scott Schlackman adds 5,000 shares in open-market buys - Stock Titan
TradingKey - TradingKey
Medifast: Worth Putting On A Watchlist (NYSE:MED) - Seeking Alpha
Why is Medifast stock surging despite weak Q1? $30M cost-cut plan - MSN
Document - SEC.gov
Medifast Q1 Loss Narrower Than Expected, Revenues Decline Y/Y - The Globe and Mail
Medifast | 8-K: Medifast Announces First Quarter 2026 Financial Results - Moomoo
Medifast, Inc. (NYSE:MED) Q1 2026 Earnings Call Transcript - Insider Monkey
Medifast Inc Stock (MED) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.02%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):